COMMUNIQUÉS West-GlobeNewswire

Cellectar Reports 2018 Second Quarter Financial Results and Provides Business Update

10/08/2018 - 14:00

MADISON, Wis., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB)(“Cellectar or “the Company”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization [...]

BioSyent Schedules Q2 2018 Earnings Release for August 22, 2018

10/08/2018 - 14:00

TORONTO, Aug. 10, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and six months ended June 30, 2018 on Wednesday, August 22, [...]

Solid Biosciences Reports Second Quarter 2018 Financial Results and Provides Business Update

10/08/2018 - 13:30

- IGNITE DMD Phase I/II Clinical Trial Patient Screening Has Resumed - CAMBRIDGE, Mass., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ:SLDB) today reported financial results for the second quarter [...]

Verona Pharma plc : PDMR Dealing & Issue of Shares

10/08/2018 - 13:12

LONDON, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

ADMA Biologics Reports Second Quarter 2018 Financial Results

10/08/2018 - 13:08

Key Regulatory & Manufacturing Milestones Achieved RAMSEY, N.J. and BOCA RATON, Fla., Aug. 10, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”) today announced its financial [...]

ReWalk Robotics to Report Second Quarter 2018 Financial Results on August 14, 2018

10/08/2018 - 13:00

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Aug. 10, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”) today announced that the Company will release its second quarter 2018 [...]

PLx Pharma Inc. Reports Second Quarter 2018 Results

10/08/2018 - 13:00

Announces that FDA has approved new name Vazalore for PLx’s next generation, novel aspirin HOUSTON, Aug. 10, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty [...]

Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD

10/08/2018 - 12:00

LIVONIA, Mich., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, [...]

MDxHealth (R) : MDxHealth Notice of Interim Results 2018

10/08/2018 - 08:17

NEWS RELEASE REGULATED INFORMATION Conference call for analysts and investors to be held on 30 August 2018 at 15:00 CEST IRVINE, CA, and HERSTAL, BELGIUM - 08.00 CEST, 10 August 2018 - MDxHealth SA (Euronext: MDXH.BR) [...]

MDxHealth (R) : Avis de publication des résultats semestriels 2018

10/08/2018 - 08:17

C ommuniqué de presse Information réglementée Une conférence téléphonique pour les analystes et les investisseurs est prévue le 30 août 2018 à 15:00 CET IRVINE, CA, et HERSTAL (BELGIQUE) - 08.00 CET, le 10 août 2018 - [...]

Shire plc : Rule 2.9 Announcement

10/08/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 10 August 2018 [...]

Interim report for the first half of 2018

10/08/2018 - 07:58

Satisfactory first half with 4% organic sales growth Organic sales growth of +4% in the first half (Q2: +5%): Household Care -1%, Food & Beverages +4%, Bioenergy +14%, Agriculture & Feed +3%, Technical & [...]

ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 14-15, 2018

10/08/2018 - 07:31

Geneva, Switzerland and Boston, MA - August 10, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for [...]

MDxHealth (R): MDxHealth Shareholder Transparency Declaration

10/08/2018 - 07:01

Press release Regulated information 7 August 2018, 7.00 p.m. CET HERSTAL, BELGIUM and IRVINE, CA - August 7, 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" or the "Company"), announced that it received on [...]

MDxHealth (R) : MDxHealth: Déclaration de Transparence d'un Actionnaire

10/08/2018 - 07:01

C ommuniqué de presse Information réglementée 7 août 2018, 07h00 HEC IRVINE, CA, et HERSTAL (BELGIQUE) - le 7 août 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" ou la "Société"), a annoncé avoir reçu le 3 [...]

NeoGenomics Announces Pricing on Public Offering of Common Stock

10/08/2018 - 02:40

FT. MYERS, Fla., Aug. 09, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO) , a leading provider of cancer-focused genetic testing services, today announced the pricing of its underwritten public offering of 9, [...]

MacroGenics to Present at Wedbush PacGrow Healthcare Conference

10/08/2018 - 00:00

ROCKVILLE, MD, Aug. 09, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

Kane Biotech Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States

09/08/2018 - 23:06

WINNIPEG, Manitoba, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) today announced the engagement of Dave D. Hood, President and Chief Executive [...]

Extendicare Announces 2018 Second Quarter Results

09/08/2018 - 23:00

MARKHAM, Ontario, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and six months ended June 30, 2018. Results are presented in Canadian [...]